Wellgistics Health (WGRX) refiles placement agent warrant exhibit in 8-K amendment
Rhea-AI Filing Summary
Wellgistics Health, Inc. filed an amendment to a prior current report to update a single exhibit. Amendment No. 2 replaces and refiles Exhibit 4.3, described as the Form of Placement Agent Warrant that was previously included with Amendment No. 1. The company states that no other disclosures or exhibits from the original report or Amendment No. 1 are modified, and the amendment does not reflect any subsequent events.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 9.01 — Financial Statements and Exhibits
1 item
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Terms
Placement Agent Warrant, Emerging growth company, Inline XBRL
3 terms
Placement Agent Warrant financial
"The purpose of this Amendment No. 2 is to replace and refile Exhibit 4.3 included with Amendment No. 1. 4.3 | | Form of Placement Agent Warrant."
Emerging growth company regulatory
"Emerging growth company Explanatory Note This Amendment No. 2"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Inline XBRL technical
"104 | | Cover Page Interactive Data File (embedded within the Inline XBRL document)."
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What is the purpose of Wellgistics Health (WGRX) Amendment No. 2?
The amendment’s sole purpose is to replace and refile Exhibit 4.3, the Form of Placement Agent Warrant. It clarifies that all other disclosures and exhibits from the original report and Amendment No. 1 remain unchanged by this new filing.
Does Wellgistics Health’s Amendment No. 2 change any prior 8-K disclosures?
The company states Amendment No. 2 does not modify or update any disclosures or exhibits from the original report or Amendment No. 1. It is limited to correcting and refiling Exhibit 4.3, keeping all other previously reported information the same.
What exhibit is being refiled in Wellgistics Health’s latest amendment?
Exhibit 4.3, identified as the Form of Placement Agent Warrant, is being replaced and refiled. This exhibit update is the only substantive change described, with all other exhibits and disclosures from earlier versions left intact by the amendment.
Does Amendment No. 2 for WGRX reflect any new corporate events?
The company specifically notes that Amendment No. 2 does not reflect any events that may have occurred after the original report. Its function is administrative, focusing solely on the corrected filing of the Placement Agent Warrant exhibit.
What exhibits are listed in Wellgistics Health’s 8-K/A Amendment No. 2?
The exhibits listed include 4.3, the Form of Placement Agent Warrant, and 104, the cover page interactive data file embedded within the Inline XBRL document. These are presented under the financial statements and exhibits section of the amendment.
Who signed Wellgistics Health’s Amendment No. 2 to the current report?
The amendment was signed on behalf of Wellgistics Health, Inc. by Prashant Patel, serving as Chief Executive Officer. His signature indicates the company’s authorization of the amended filing and the updated Placement Agent Warrant exhibit included with it.